Magnapen (ampicillin flucloxacillin): Reviews and patient testimonials

Magnapen 250mg/250mg Powder for Solution for Injection or Infusion

Co-fluampicil is indicated for the treatment of severe infections where the causative organism is unknown, and for mixed infections involving β-lactamase-producing staphylococci. Typical indications include:

In general practice: Chest infections, ENT infections, skin and soft tissue infections, and infections in patients whose underlying pathology places them at special risk.

In hospital (prior to laboratory results being available): severe respiratory tract infections, post-operative chest and wound infections, septic abortion, puerperal fever; septicaemia, prophylaxis in major surgery, infections in patients receiving immuno-suppressive therapy.

The spectrum of activity of co-fluampicil also makes it suitable for the treatment of many mixed infections, particularly those where β-lactamase-producing staphylococci are suspected or confirmed.

Parenteral usage is indicated where oral dosage is inappropriate.

Route of administration: Injectable
Molecule: ampicillin, flucloxacillin